Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $54.60 ($2.1M) on 2019-04-03, disclosed to the SEC on 2019-04-05.
Scheduled sale ($2.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.60 | 1,418 | $77K | 3.6% |
| 2 | $54.63 | 18,200 | $994K | 46.4% |
| 3 | $55.24 | 200 | $11K | 0.5% |
| 4 | $53.12 | 1,118 | $59K | 2.8% |
| 5 | $53.17 | 13,900 | $739K | 34.5% |
| 6 | $53.97 | 200 |
| $11K |
| 0.5% |
| 7 | $54.24 | 2,700 | $146K | 6.8% |
| 8 | $55.13 | 100 | $6K | 0.3% |
| 9 | $55.14 | 1,800 | $99K | 4.6% |
| Total | $54.07 avg | 39,636 | $2.1M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |